Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
EWTX
Showing 8 of 16 quarters
Position history for RA Capital Management, L.P.'s holdings in Edgewise Therapeutics, Inc.
Yes. RA Capital Management holds 8,392,730 shares of EWTX (Edgewise Therapeutics), worth $341M, as of its Q2 2026 13F filing. It reduced the position by 2,035,707 shares (-19.5%) from Q1 2026. RA Capital Management has held EWTX since Q1 2024, across 10 quarterly 13F filings. EWTX is 3.0% of RA Capital Management's reported 13F portfolio.
Current Value
$341M
Current Shares
8.4M
Total Value Change
+$103.2M
Total Shares Change
-516,361
Quarter-by-Quarter History